Clinical trial
Effectiveness of a Digital Health Application for Multiple Sclerosis (Levidex): Randomized Controlled Trial
NCT06090305 is registered in ClinicalTrials.gov with Gaia AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of a Digital Health Application for Multiple Sclerosis (Levidex): Randomized Controlled Trial
- Lead sponsor
- Gaia AG
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 20, 2023
- Completion date
- December 6, 2024
- Enrollment
- 470 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.